Definition — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Primero connects legacy tools, records, spreadsheets, and internal APIs into a semantic layer and deploys AI agents and applications inside real business workflows, with an emphasis on auditability, data residency, and control.
AI & Machine LearningData & InfrastructureEnterprise SoftwareMexico City, MX
José Murillo(Co-CEO)inAndrés Rosales(Co-CEO)inSantiago Buenahora(CTO)in
Co-investorsGeneral Catalyst8VCConvictionKaszek Ventures
Cogent builds an AI-native vulnerability management platform that uses AI agents to detect exposure shortly after disclosure, prioritize risks by real exploitability and business impact, remediate through existing workflow tools, and generate natural-language reporting with audit evidence.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaSSan Francisco, US
Thanos Baskous(Co-Founder & VP of Engineering)inVineet Edupuganti(Co-Founder & CEO)inGeng Sng(Co-Founder & CTO)inGeng Gng(Co-founder)in
BoardEnrique Salem(Board Member (Partner & Managing Director, Bain Capital Ventures))Corinne Riley(Board Member (Partner, Greylock Partners))
Co-investorsArtisanal VenturesBain Capital VenturesGreylock PartnersPaladin Capital Group
AI & Machine LearningDeep TechMobility & TransportationRoboticsSunnyvale, US
Bibhrajit Halder(Executive Officer, Director)
BoardAlexei Andreev(Director)in
Co-investorsFoundamentalMonta Vista CapitalAutotech VenturesBain Capital VenturesBrick Mortar VenturesBuilders VC+7 more
Simile builds AI-driven simulation software using generative agents to model how customers, employees, or populations respond to change, helping organizations test decisions before acting.
AI & Machine LearningEnterprise SoftwareSaaSBrooklyn, US
Joon Sung Park(Co-founder)inMichael Bernstein(Co-founder)inPercy Liang(Co-founder)Lainie Yallen(Co-founder)inJames George(Executive Officer, Director)Alexander Porter(Executive Officer, Director)
Co-investorsA*Bain Capital VenturesIndex VenturesCVS Health VenturesGreenoaks
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.